Medscape Hematology-Oncology Headlines This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

This Test May Guide AML Therapy for Black Pediatric Patients This Test May Guide AML Therapy for Black Pediatric Patients
A new analysis suggests that a polygenic score can help determine the best drug regimens for young Black patients with AML who often face worse outcomes than White patients.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 9, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

Can Younger Postmenopausal Women With BC Skip Radiation? Can Younger Postmenopausal Women With BC Skip Radiation?
Women aged 65-70 years old are often offered the option of skipping radiation after lumpectomy for hormone receptor –positive early-stage breast cancer and moving straight to endocrine therapy.MDedge News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 8, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

Combined Rituximab + Omalizumab Promising for Refractory BP Combined Rituximab + Omalizumab Promising for Refractory BP
Bullous pemphigoid has high morbidity and mortality, especially in people with comorbidities common to older adults, yet no Food and Drug Administration –approved therapies for BP exist.MDedge News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 8, 2023 Category: Cancer & Oncology Tags: Dermatology Source Type: news

Trop-2 Drug Conjugate May Trump Chemo in HR+, HER2- BRCA Trop-2 Drug Conjugate May Trump Chemo in HR+, HER2- BRCA
If approved, the ADC would join sacituzumab govitecan (Trodelvy, Gilead) as agents that target trophoblast cell-surface antigen-2 (Trop-2), which is universally expressed in breast cancer.MDedge News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 8, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

Patients With HR-Positive Breast Cancer Can Safely Use ART Patients With HR-Positive Breast Cancer Can Safely Use ART
New data from the POSITIVE trial show the efficacy and short-term safety of fertility preservation and assisted reproductive technology (ART) for young women with HR-positive breast cancer.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 8, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

FDA OKs Two Gene-Editing Therapies for Sickle Cell Disease FDA OKs Two Gene-Editing Therapies for Sickle Cell Disease
The approval for the two gene-editing treatments, called exa-cel and lovo-cel, could help thousands with the blood disorder.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 8, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

Hematology Is in the Brodsky Family's Blood Hematology Is in the Brodsky Family's Blood
Talk about bloodlines: In the Brodsky family, the field of hematology tied father to son. Now, a grandson is heading into the " family business. "MDedge News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 8, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

Sleep Problems Exact High Toll in Women With Breast Cancer Sleep Problems Exact High Toll in Women With Breast Cancer
It ' s important to ask about sleep and provide targeted interventions to improve sleep and quality of life in women with breast cancer, researchers say.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 7, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

When to Skip Regional Nodal Radiation in Breast Cancer When to Skip Regional Nodal Radiation in Breast Cancer
When neoadjuvant chemotherapy turns positive lymph nodes negative, 5-year survival outcomes are the same whether patients have regional nodal irradiation or not.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 7, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

Compelling Case for Skipping RT in Some Early Breast Cancers Compelling Case for Skipping RT in Some Early Breast Cancers
Results of the PROSPECT study have defined a role for preoperative MRI in identifying a subgroup of women with early breast cancer who could consider skipping radiation therapy.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 7, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

How Can Dermatologists Improve Cancer Care? How Can Dermatologists Improve Cancer Care?
Dermatologists play a key role on interdisciplinary treatment teams.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 7, 2023 Category: Cancer & Oncology Tags: Dermatology Source Type: news

FDA OKs Iptacopan to Treat Paroxysmal Nocturnal Hemoglobinuria FDA OKs Iptacopan to Treat Paroxysmal Nocturnal Hemoglobinuria
This marks the first oral monotherapy approved for the rare blood disorder.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 6, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

What Will Help Ease the Financial Toll of Breast Cancer? What Will Help Ease the Financial Toll of Breast Cancer?
Programs that offer financial assistance and transportation as well as grants that help cover expenses are among the key strategies that can help reduce the financial stress of breast cancer care.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 6, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

Even With Insurance, Cancer OOP Costs Can Be Punishing Even With Insurance, Cancer OOP Costs Can Be Punishing
Commercial health insurance does not necessarily protect cancer patients from potentially devastating out-of-pocket costs.MDedge News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 5, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

ASH 2023: Equity, Sickle Cell, and Real-Life Outcomes ASH 2023: Equity, Sickle Cell, and Real-Life Outcomes
Health equity, sickle cell disease, and the thoughtful use of artificial intelligence and social media are among the key themes to be presented at the annual meeting of the American Society of Hematology.MDedge News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 5, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news